Why should we need the gut microbiota to respond to cancer therapies?
2014
Viaud, Sophie | Daillere, Romain | Yamazaki, Takahiro | Lepage, Patricia | Boneca, Ivo | Goldszmid, Romina | Trinchieri, Giorgio | Zitvogel, Laurence
Cyclophosphamide, one of the most efficient tumoricidal, antiangiogenic, and immunostimulatory drugs employed to date mediates part of its effects through intestinal bacteria, against which the host becomes immunized during treatment. Our recent work suggests that anti-commensal effector pT(H)17 and memory T(H)1 CD4(+) T-cell responses are indispensable for optimal anticancer effects as mediated by cyclophosphamide.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
其它主题
Immunomodulateur; Pth17; Immunomodulatory regimen
语言
英语
类型
Journal Article
2016-06-15
2025-12-04
AGRIS AP